Article | June 29, 2022

Drug Metabolism, Pharmacokinetics Strategies To Avoid Drug Development Mistakes Early

GettyImages-1218520471-development-research-lab-PPE

Accurate data and insightful analysis of the Drug Metabolism, Pharmacokinetics (DMPK), Absorption, Distribution, Metabolism, and Excretion (ADME) properties of your compounds is a critical part of the drug discovery journey and helps you shortlist candidates with the highest chances of success in the later stages of drug development. The right partner for your DMPK ADME needs can help you reduce compound failure, identify compounds with optimal safety profiles, and minimize drug-drug interactions in later stages.

In this point of view, we discuss some DMPK strategies to avoid drug development mistakes early. These strategies have helped Syngene scientists drive cost-effective, reproducible, high-quality data for our clients, thereby enabling faster movement of molecules from bench to bedside. So far, Syngene has worked with 117 global clients, conducting nearly 3500 PK studies/year.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online